| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 09/15/2011 | WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 09/15/2011 | WO2011110859A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | WO2011110858A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | WO2011110613A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | WO2011110546A2 Pharmaceutical composition comprising an inhibitor of shp-2 and screening method |
| 09/15/2011 | WO2011110225A1 Adhesive patch for therapeutic agent delivery |
| 09/15/2011 | WO2011109900A1 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
| 09/15/2011 | WO2011069921A9 Sucrose octasulfates of zinc, the preparation of same and the pharmaceutical and cosmetic uses thereof |
| 09/15/2011 | US20110224675 Minimally invasive treatment of vertebra (mitv) using a calcium phosphate combination bone cement |
| 09/15/2011 | US20110224447 Novel Lipid Nanoparticles and Novel Components for Delivery of Nucleic Acids |
| 09/15/2011 | US20110224302 Difluorophenyldiacylhydrazide derivatives |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224283 Antisense modulation of nuclear hormone receptors |
| 09/15/2011 | US20110224267 Selective androgen receptor modulators |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224261 Crystalline form of 4-(5--4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 09/15/2011 | US20110224255 Tripeptidyl peptidase inhibitors |
| 09/15/2011 | US20110224254 Novel inhibitors |
| 09/15/2011 | US20110224251 Therapeutic Pyrazolyl Thienopyridines |
| 09/15/2011 | US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 09/15/2011 | US20110224229 Novel Crystalline Form |
| 09/15/2011 | US20110224223 MTOR Modulators and Uses Thereof |
| 09/15/2011 | US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof |
| 09/15/2011 | US20110224209 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 09/15/2011 | US20110224192 3-Arylamino Pyridine Derivatives |
| 09/15/2011 | US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224169 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 09/15/2011 | US20110224166 COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended) |
| 09/15/2011 | US20110224143 Nucleobindin i variant protein compositions and methods of use |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223266 Beverage and medicament containing bamboo extract as a main ingredient |
| 09/15/2011 | US20110223252 Electrolyte purgative |
| 09/15/2011 | US20110223251 Bacterial composition |
| 09/15/2011 | US20110223248 Methods and compositions for treating lactose intolerance |
| 09/15/2011 | US20110223193 Method for the preparation of medical devices and devices obtained therefrom |
| 09/15/2011 | US20110223192 Methods for delaying the onset and/or reducing the severity of metabolic syndrome |
| 09/15/2011 | US20110223164 Binding domain-immunoglobulin fusion proteins |
| 09/15/2011 | US20110223155 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/15/2011 | US20110223137 Compositions for use in low-birth weight infants |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223108 Glucagon-like peptide-2 and its therapeutic use |
| 09/15/2011 | CA2792726A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | CA2792725A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2792392A1 The use of amisulpride as an anti-emetic |
| 09/15/2011 | CA2792157A1 Arylvinylazacycloalkane compounds for constipation |
| 09/15/2011 | CA2791418A1 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
| 09/15/2011 | CA2789440A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/14/2011 | EP2365075A1 Method for inhibiting the expression of a target gene and medicine for treating a tumour illness |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364979A1 Pyrrole compounds |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364718A1 Enzyme treatment of foodstuffs for celiac sprue |
| 09/14/2011 | EP2364708A2 Pharmaceutical composition comprising a C1C-2 channel opener |
| 09/14/2011 | EP2225222B1 A quinoline derivative acting as a p2x7-receptor antagonist |
| 09/14/2011 | EP2076271B1 Inhibition of cholera toxins by galatooligosaccharides (gos) |
| 09/14/2011 | EP1893211B1 Use of sanglifehrin in hcv |
| 09/14/2011 | EP1713480B1 The use of quaternary pyridinium salts as vasoprotective agents |
| 09/14/2011 | EP1471915B1 2,4-pyrimidinediamine compounds and their uses |
| 09/14/2011 | EP1346982B1 Vla-4 inhibitors |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | EP1112003B2 Use of a viscosity modulating polymer material for reducing tooth erosion |
| 09/14/2011 | CN1903357B Liver hydrolytic peptide for injection and preparation method therefor |
| 09/14/2011 | CN1842329B Preventive or ameliorating agent for liver disease involving hepatopathy |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN102186881A Glucagon-likepeptide1 derivatives and use thereof |
| 09/14/2011 | CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186840A Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 09/14/2011 | CN102186839A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186838A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186472A Treatment |
| 09/14/2011 | CN102186360A Nutritional composition with anti-regurgitation properties |
| 09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 09/14/2011 | CN102181457A Clostridium difficile exotoxin B amino-terminal gene sequence with optimized codon and nucleic vaccine of clostridium difficile exotoxin B |
| 09/14/2011 | CN102181400A Hybridoma cell strain and anti-HCCLM-6 (Human Hepatoma Cell Line) cell secretory protein monoclonal antibody |
| 09/14/2011 | CN102180995A Method for extracting synanthrin from jerusalem artichoke |
| 09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
| 09/14/2011 | CN102180890A Cefathiamidine hydrate and preparation method and application thereof |
| 09/14/2011 | CN102180889A Ceftizoxime sodium crystalline hydrate and preparation method and application thereof |
| 09/14/2011 | CN102180866A New crystal form of lansoprazole and preparation method and application thereof |
| 09/14/2011 | CN102180861A Bicyclol valine ester as well as preparation method, pharmaceutical composition and application thereof |
| 09/14/2011 | CN102178956A Preparation, medical application and composition of 20S-protopanaxadiol beta-cyclodextrin inclusion compound |
| 09/14/2011 | CN102178953A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 09/14/2011 | CN102178941A Novel helicobacter pylori multiepitope vaccine and preparation method thereof |
| 09/14/2011 | CN102178937A Pharmaceutical composition for protecting liver and benefiting spleen and preparation method thereof |
| 09/14/2011 | CN102178927A Application of interferon-induced transmembrane protein 3 (IFITM 3) for preparing medicament against hepatitis B virus (HBV) infection |
| 09/14/2011 | CN102178926A Peptide for preventing or treating liver damage |
| 09/14/2011 | CN102178914A Chinese medicinal composition for treating gastrointestinal disease and preparation method thereof |
| 09/14/2011 | CN102178912A Chinese medicine preparation for relieving gastral cavity crymodynia symptoms of people with yang deficiency as well as preparation method and application thereof |
| 09/14/2011 | CN102178905A Chinese medicine body surface application therapeutic technology and Chinese medicine combinations |
| 09/14/2011 | CN102178903A Method for preparing traditional Chinese medicine for treating acute pancreatitis caused by overeating greasy food |
| 09/14/2011 | CN102178902A Method for preparing Chinese medicine for treating liver stagnation type acute pancreatitis |
| 09/14/2011 | CN102178900A Lucid ganoderma and radix semiaquilegiaedecoction for treating primary biliary cirrhosis |
| 09/14/2011 | CN102178897A Traditional Chinese medicament for treating reflux esophagitis |
| 09/14/2011 | CN102178891A Chinese medicinal dispersible tablets for treating gastritis and preparation method thereof |